MedTrace Logo

Tolerance of Infants Fed a Hydrolysate Formula

NCT03628183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2018-12-19

No results posted yet for this study

Summary

This is a prospective, randomized, multicenter study to assess the tolerance of infant formulas.

Conditions

  • Gastrointestinal Tolerance

Interventions

OTHER

Hydrolysate Infant Formula 1

Feed ad lib

OTHER

Hydrolysate Infant Formula 2

Feed ad lib

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Courtney Allgeier, MS, RD, LD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-28
Primary Completion
2018-11-23
Completion
2018-11-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03628183 on ClinicalTrials.gov